Endometriosis Market Report

Global and Region Endometriosis Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：199
  • REPORT CODE：GMM975000
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.

    The report details the trend, potential and market size of Endometriosis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Endometriosismarket, defines the market attractiveness level of Endometriosis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Endometriosis industry, describes the types of Endometriosis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Endometriosis market and the development prospects and opportunities of Endometriosis industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Endometriosis market in Chapter 13.

    By Player:

    • Euroscreen

    • Debiopharm

    • AbbVie

    • Pfizer

    • Neurocrine Biosciences

    • Addex Therapeutics

    • Takeda

    • Nippon Shinyaku

    • Astellas Pharma

    • Kissei Pharmaceutical

    • Bayer HealthCare

    • Forendo Pharma

    • EndoCeutics

    • AstraZeneca

    By Type:

    • Gonadotropins Releasing Hormone Agonists

    • Non-Steroidal Anti-Inflammatory Drugs

    • Progestin

    • Oral Contraceptive Pills

    By End-User:

    • Hospitals

    • Pharmacies

    • E-commerce

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Endometriosis Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Endometriosis Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Endometriosis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Endometriosis Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Endometriosis Market Analysis and Outlook to 2022

    • 7.1 Global Endometriosis Consumption (2017-2022)

    • 7.2 United States Endometriosis Consumption (2017-2022)

    • 7.3 Europe Endometriosis Consumption (2017-2022)

    • 7.4 China Endometriosis Consumption (2017-2022)

    • 7.5 Japan Endometriosis Consumption (2017-2022)

    • 7.6 India Endometriosis Consumption (2017-2022)

    • 7.7 South Korea Endometriosis Consumption (2017-2022)

    8 Region and Country-wise Endometriosis Market Analysis and Outlook to 2028

    • 8.1 Global Endometriosis Consumption Forecast (2022-2028)

    • 8.2 United States Endometriosis Consumption Forecast (2022-2028)

    • 8.3 Europe Endometriosis Consumption Forecast (2022-2028)

    • 8.4 China Endometriosis Consumption Forecast (2022-2028)

    • 8.5 Japan Endometriosis Consumption Forecast (2022-2028)

    • 8.6 India Endometriosis Consumption Forecast (2022-2028)

    • 8.7 South Korea Endometriosis Consumption Forecast (2022-2028)

    9 Global Endometriosis Market Outlook by Types and Applications to 2022

    • 9.1 Global Endometriosis Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Gonadotropins Releasing Hormone Agonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Progestin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Oral Contraceptive Pills Consumption and Growth Rate (2017-2022)

    • 9.2 Global Endometriosis Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global E-commerce Consumption and Growth Rate (2017-2022)

    10 Global Endometriosis Market Outlook by Types and Applications to 2028

    • 10.1 Global Endometriosis Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Gonadotropins Releasing Hormone Agonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Progestin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Oral Contraceptive Pills Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Endometriosis Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global E-commerce Consumption Forecast and Growth Rate (2022-2028)

    11 Global Endometriosis Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Endometriosis Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Endometriosis Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Endometriosis Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Endometriosis Market Competitive Analysis

    • 14.1 Euroscreen

      • 14.1.1 Euroscreen Company Details

      • 14.1.2 Euroscreen Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Euroscreen Endometriosis Product and Service

    • 14.2 Debiopharm

      • 14.2.1 Debiopharm Company Details

      • 14.2.2 Debiopharm Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Debiopharm Endometriosis Product and Service

    • 14.3 AbbVie

      • 14.3.1 AbbVie Company Details

      • 14.3.2 AbbVie Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AbbVie Endometriosis Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Endometriosis Product and Service

    • 14.5 Neurocrine Biosciences

      • 14.5.1 Neurocrine Biosciences Company Details

      • 14.5.2 Neurocrine Biosciences Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Neurocrine Biosciences Endometriosis Product and Service

    • 14.6 Addex Therapeutics

      • 14.6.1 Addex Therapeutics Company Details

      • 14.6.2 Addex Therapeutics Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Addex Therapeutics Endometriosis Product and Service

    • 14.7 Takeda

      • 14.7.1 Takeda Company Details

      • 14.7.2 Takeda Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Takeda Endometriosis Product and Service

    • 14.8 Nippon Shinyaku

      • 14.8.1 Nippon Shinyaku Company Details

      • 14.8.2 Nippon Shinyaku Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nippon Shinyaku Endometriosis Product and Service

    • 14.9 Astellas Pharma

      • 14.9.1 Astellas Pharma Company Details

      • 14.9.2 Astellas Pharma Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Astellas Pharma Endometriosis Product and Service

    • 14.10 Kissei Pharmaceutical

      • 14.10.1 Kissei Pharmaceutical Company Details

      • 14.10.2 Kissei Pharmaceutical Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Kissei Pharmaceutical Endometriosis Product and Service

    • 14.11 Bayer HealthCare

      • 14.11.1 Bayer HealthCare Company Details

      • 14.11.2 Bayer HealthCare Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Bayer HealthCare Endometriosis Product and Service

    • 14.12 Forendo Pharma

      • 14.12.1 Forendo Pharma Company Details

      • 14.12.2 Forendo Pharma Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Forendo Pharma Endometriosis Product and Service

    • 14.13 EndoCeutics

      • 14.13.1 EndoCeutics Company Details

      • 14.13.2 EndoCeutics Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 EndoCeutics Endometriosis Product and Service

    • 14.14 AstraZeneca

      • 14.14.1 AstraZeneca Company Details

      • 14.14.2 AstraZeneca Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 AstraZeneca Endometriosis Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Endometriosis

    • Figure Endometriosis Picture

    • Table Global Endometriosis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Endometriosis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Endometriosis Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Endometriosis Consumption by Country (2017-2022)

    • Figure United States Endometriosis Consumption and Growth Rate (2017-2022)

    • Table Europe Endometriosis Consumption and Growth Rate (2017-2022)

    • Figure China Endometriosis Consumption and Growth Rate (2017-2022)

    • Figure Japan Endometriosis Consumption and Growth Rate (2017-2022)

    • Figure India Endometriosis Consumption and Growth Rate (2017-2022)

    • Figure South Korea Endometriosis Consumption and Growth Rate (2017-2022)

    • Figure Global Endometriosis Consumption Forecast by Country (2022-2028)

    • Figure United States Endometriosis Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Endometriosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Endometriosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Endometriosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Endometriosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Endometriosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gonadotropins Releasing Hormone Agonists Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Progestin Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Contraceptive Pills Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global E-commerce Consumption and Growth Rate (2017-2022)

    • Figure Global Gonadotropins Releasing Hormone Agonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Progestin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Contraceptive Pills Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global E-commerce Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Endometriosis Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Endometriosis Export by Region (Top 5 Countries) (2017-2028)

    • Table Euroscreen (Foundation Year, Company Profile and etc.)

    • Table Euroscreen Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Euroscreen Endometriosis Product and Service

    • Table Debiopharm (Foundation Year, Company Profile and etc.)

    • Table Debiopharm Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Debiopharm Endometriosis Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Endometriosis Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Endometriosis Product and Service

    • Table Neurocrine Biosciences (Foundation Year, Company Profile and etc.)

    • Table Neurocrine Biosciences Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurocrine Biosciences Endometriosis Product and Service

    • Table Addex Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Addex Therapeutics Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Addex Therapeutics Endometriosis Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Endometriosis Product and Service

    • Table Nippon Shinyaku (Foundation Year, Company Profile and etc.)

    • Table Nippon Shinyaku Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nippon Shinyaku Endometriosis Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Endometriosis Product and Service

    • Table Kissei Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kissei Pharmaceutical Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kissei Pharmaceutical Endometriosis Product and Service

    • Table Bayer HealthCare (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Endometriosis Product and Service

    • Table Forendo Pharma (Foundation Year, Company Profile and etc.)

    • Table Forendo Pharma Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Forendo Pharma Endometriosis Product and Service

    • Table EndoCeutics (Foundation Year, Company Profile and etc.)

    • Table EndoCeutics Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table EndoCeutics Endometriosis Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Endometriosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Endometriosis Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US